Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients

Bibliographic Details
Main Author: Claes, Donna
Language:English
Published: University of Cincinnati / OhioLINK 2013
Subjects:
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870677
id ndltd-OhioLink-oai-etd.ohiolink.edu-ucin1377870677
record_format oai_dc
spelling ndltd-OhioLink-oai-etd.ohiolink.edu-ucin13778706772021-08-03T06:19:39Z Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients Claes, Donna Surgery pediatric renal transplantation non-adherence donor specific antibodies immunosuppression drug monitoring Previous studies associating non-adherence with donor specific antibodies (DSA) development in renal transplant recipients have used subjective assessments to classify non-adherence. No studies have examined the association between objective measures of non-adherence – primarily, standard deviation and/or coefficient of variation of immunosuppressive drug levels - and DSA development. We retrospectively analyzed the standard deviation and coefficient of variation in the five most recent tacrolimus or sirolimus trough drug levels at the time of DSA testing in 69 low-to-standard immunologic risk, first-time pediatric renal transplant recipients followed at a single US pediatric nephrology center. DSA prevalence in the population was 38% (n=26). DSA+ patients had significantly higher standard deviation (p=0.014) and coefficient of variation (p=0.024). There was a trend towards increased DSA prevalence in patients taking sirolimus vs. tacrolimus (p=0.14). Multivariate logistic regression demonstrated that coefficient of variation (p = 0.03) and black race (p=0.012) retained statistical significance in DSA development. For each 10% increase in coefficient of variation, the odds of developing a DSA increased by almost 40% (adj OR 1.38, 95% CI 1.09, 1.75). Future studies are needed to understand the extent and length of time variations in immunosuppressant medications that are tolerated prior to DSA formation. 2013-10-28 English text University of Cincinnati / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870677 http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870677 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.
collection NDLTD
language English
sources NDLTD
topic Surgery
pediatric renal transplantation
non-adherence
donor specific antibodies
immunosuppression drug monitoring
spellingShingle Surgery
pediatric renal transplantation
non-adherence
donor specific antibodies
immunosuppression drug monitoring
Claes, Donna
Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients
author Claes, Donna
author_facet Claes, Donna
author_sort Claes, Donna
title Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients
title_short Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients
title_full Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients
title_fullStr Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients
title_full_unstemmed Increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients
title_sort increased variation in immunosuppressive drug monitoring is associated with the development of donor specific antibodies in pediatric renal transplant recipients
publisher University of Cincinnati / OhioLINK
publishDate 2013
url http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870677
work_keys_str_mv AT claesdonna increasedvariationinimmunosuppressivedrugmonitoringisassociatedwiththedevelopmentofdonorspecificantibodiesinpediatricrenaltransplantrecipients
_version_ 1719434731756453888